Breast cancer genome and transcriptome integration implicates specific mutational signatures with immune cell infiltration.

Nat Commun 2016 Sep 26;7:12910. Epub 2016 Sep 26.

Department of Medical Oncology, Erasmus MC Cancer Institute and Cancer Genomics Netherlands, Erasmus University Medical Center, 3015CN Rotterdam, The Netherlands.

A recent comprehensive whole genome analysis of a large breast cancer cohort was used to link known and novel drivers and substitution signatures to the transcriptome of 266 cases. Here, we validate that subtype-specific aberrations show concordant expression changes for, for example, TP53, PIK3CA, PTEN, CCND1 and CDH1. We find that CCND3 expression levels do not correlate with amplification, while increased GATA3 expression in mutant GATA3 cancers suggests GATA3 is an oncogene. In luminal cases the total number of substitutions, irrespective of type, associates with cell cycle gene expression and adverse outcome, whereas the number of mutations of signatures 3 and 13 associates with immune-response specific gene expression, increased numbers of tumour-infiltrating lymphocytes and better outcome. Thus, while earlier reports imply that the sheer number of somatic aberrations could trigger an immune-response, our data suggests that substitutions of a particular type are more effective in doing so than others.

Download full-text PDF

Source
http://www.nature.com/articles/ncomms12910
Publisher Site
http://dx.doi.org/10.1038/ncomms12910DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5052682PMC
September 2016
109 Reads

Publication Analysis

Top Keywords

breast cancer
8
gene expression
8
expression
5
luminal cases
4
cases total
4
oncogene luminal
4
gata3 oncogene
4
cancers suggests
4
suggests gata3
4
total number
4
number substitutions
4
type associates
4
associates cell
4
irrespective type
4
substitutions irrespective
4
gata3 cancers
4
cell cycle
4
expression mutant
4
cdh1 find
4
find ccnd3
4

References

(Supplied by CrossRef)

LB Alexandrov et al.
Nature 2013

S Banerji et al.
Nature 2012

C Curtis et al.
Nature 2012

S Nik-Zainal et al.
Cell 2012

ER Paquet et al.
J. Natl Cancer Inst. 2015

ED Pleasance et al.
Nature 2010

PJ Stephens et al.
Nature 2012

S Nik-Zainal et al.
Nature 2016

CM Perou et al.
Nature 2000

M Smid et al.
Cancer Res. 2008

Similar Publications